eNOS gene polymorphism association with retinopathy in type 1 diabetes

Area of Science:

• Genetics and Molecular Biology
• Vascular Biology
• Endocrinology

Background:

• Nitric oxide (NO) is crucial for vascular health, regulating blood pressure and flow.
• Dysregulation of NO production is implicated in diabetes and its microvascular complications.
• Endothelial nitric oxide synthase (eNOS) is a key enzyme in NO synthesis, relevant to angiopathies.

Purpose of the Study:

• To investigate the association between a single nucleotide polymorphism (-786 C/T) in the eNOS gene and type 1 diabetes mellitus (T1DM).
• To determine the influence of this eNOS gene polymorphism on the development of microvascular complications, specifically diabetic retinopathy, in T1DM patients.

Main Methods:

• A case-control association study was conducted on 249 British Caucasian individuals with T1DM.
• Genotyping for the eNOS -786 C/T polymorphism was performed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique.
• Genotype and allele frequencies were compared between diabetic patients (with and without retinopathy) and healthy controls.

Main Results:

• A significant association was found between the eNOS -786 C/T polymorphism and both T1DM and diabetic retinopathy.
• Genotype frequencies differed significantly between diabetic patients and controls (p=0.05, OR=1.5) and between diabetic retinopaths and controls (p=0.0000, OR=3.4).
• No significant differences were observed for eNOS allele and genotype frequencies in other studied diabetic complication groups compared to controls.

Conclusions:

• Variation in the eNOS gene may contribute to the genetic susceptibility to T1DM and diabetic retinopathy.
• This eNOS gene polymorphism could have prognostic value for identifying individuals at higher risk of developing diabetic retinopathy.
• Findings suggest potential interventional strategies targeting eNOS regulation in diabetic patients.